文献速递流行病学与生物统计医学教育与科研方法

Cochrane非随机研究偏倚风险工具(ROBINS-I)常被误用:一项方法学系统综述

Cochrane's risk of bias tool for non-randomized studies (ROBINS-I) is frequently misapplied: A methodological systematic review.
PubMed 文献 · J Clin Epidemiol · 2021-08-23

该研究通过数据库和引文检索2020年3月前使用ROBINS-I的系统综述,纳入124篇综述,提取ROBINS-I评估数据并用AMSTAR 2评价综述质量。结果显示平均54%的评估为严重/极严重偏倚风险,常见于混杂;综述质量多偏低,20%修改评分量表、20%低估总体偏倚风险、19%将极严重偏倚风险研究纳入证据合成,低质量综述更易报告低/中等偏倚风险。

要点

  • ROBINS-I在系统综述中常被修改或错误应用,读者需警惕结论可靠性。
  • 平均54%的ROBINS-I评估为严重/极严重偏倚风险,主要源于混杂。
  • 低质量综述更易报告低/中等偏倚风险,可能不当纳入或权重过高不确定证据。

核心结论

  • 低质量综述频繁错误应用ROBINS-I,可能不当纳入或过度重视不确定证据,导致错误结论。

研究设计与样本

  • 方法学系统综述,于2020年3月进行数据库和引文检索,纳入124篇近期使用ROBINS-I的系统综述,提取ROBINS-I评估数据并用AMSTAR 2评价综述质量。

主要发现

  • 平均54%的ROBINS-I评估为严重/极严重偏倚风险,最常见原因是混杂。
  • 20%的综述修改了ROBINS-I评分量表,20%低估总体偏倚风险,19%将极严重偏倚风险研究纳入证据合成。
  • 低质量综述更易报告低/中等偏倚风险:极低质量综述预测概率57%(95%CI:47-67),高/中等质量综述31%(19-46)。

临床怎么用

  • 阅读使用ROBINS-I的系统综述时,应关注其是否修改评分量表、是否低估偏倚风险、是否纳入极严重偏倚风险研究,并参考AMSTAR 2质量评价。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We aimed to review how 'Risk of Bias In Non-randomized Studies-of Interventions' (ROBINS-I), a Cochrane risk of bias assessment tool, has been used in recent systematic reviews. STUDY DESIGN AND SETTING: Database and citation searches were conducted in March 2020 to identify recently published reviews using ROBINS-I. Reported ROBINS-I assessments and data on how ROBINS-I was used were extracted from each review. Methodological quality of reviews was assessed using AMSTAR 2 ('A MeaSurement Tool to Assess systematic Reviews'). RESULTS: Of 181 hits, 124 reviews were included. Risk of bias was serious/critical in 54% of assessments on average, most commonly due to confounding. Quality of reviews was mostly low, and modifications and incorrect use of ROBINS-I were common, with 20% reviews modifying the rating scale, 20% understating overall risk of bias, and 19% including critical-risk of bias studies in evidence synthesis. Poorly conducted reviews were more likely to report low/moderate risk of bias (predicted probability 57% [95% CI: 47-67] in critically low-quality reviews, 31% [19-46] in high/moderate-quality reviews). CONCLUSION: Low-quality reviews frequently apply ROBINS-I incorrectly, and may thus inappropriately include or give too much weight to uncertain evidence. Readers should be aware that such problems can lead to incorrect conclusions in reviews.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Igelström E, Campbell M, Craig P, et al. Cochrane's risk of bias tool for non-randomized studies (ROBINS-I) is frequently misapplied: A methodological systematic review. J Clin Epidemiol. 2021. PMID: 34437948. doi:10.1016/j.jclinepi.2021.08.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。